Home
|
Inbox
|
Search
|
Speaker
Frank C. Albers
MD, PhD
GlaxoSmithKline;GSK
Session(s)
- Durability of Clinical Response Following Long-Term Treatment with Mepolizumab in Patients...
Sunday, May 20 11:15 AM - 1:00 PM - Effect of Mepolizumab (100 mg Subcutaneous) on Exacerbation Rate in Patients with Severe E...
Sunday, May 20 11:15 AM - 1:00 PM - Long-Term Safety of Mepolizumab in Patients with Severe Eosinophilic Asthma: The COLUMBA S...
Sunday, May 20 11:15 AM - 1:00 PM - Characteristics and Outcomes of COPD Patients with Blood Eosinophils ≥150 Cells/µL Who Con...
Monday, May 21 11:15 AM - 1:00 PM - Identifying Eosinophilic Asthma in ICD-10 [Board No. P22]
Tuesday, May 22 11:15 AM - 1:00 PM - Measuring Burden of Oral Corticosteroids in US and German Patients with Severe Asthma [Boa...
Tuesday, May 22 11:15 AM - 1:00 PM
|
Home
|
Inbox
|
Search
|